Abstract:Sepsis is a systemic inflammatory response syndrome caused by infection, and is a common disease in intensive care units (ICUs), whereby the mortality rate is as high as 30% to 50%. Early diagnosis and treatment can significantly reduce the mortality rate of patients with sepsis. We have developed a method based on SERS for the rapid and quantitative detection of IL-6. Using the principle of double antibody sandwich, the core-shell nanoparticles embedded with a Raman reporter (Au@4MBA@Ag NPs) are coupled to the tracer antibody, while the biotin was coupled to the capture antibody to form an antibody-antigen-antibody sandwich structure with the antigen during detection of the structure. Streptavidin (SA) and biotin had a strong affinity, and the sandwich structure was captured by SA magnetic beads and detected by Raman spectroscopy under the enrichment of an external magnetic field. The results showed a good linear relationship between the Raman signal and the concentration of IL-6 in the concentration range of 0-1000 pg mL-1 (r = 0.9997) with a limit of detection of 1.6 pg mL-1. Also, the recovery rate of standard addition was 93.9-99.1%, and the coefficient of variation intra-assay and inter-assay of the three batches of reagents was less than 15%. Furthermore, it showed excellent specificity with procalcitonin (PCT, 20 ng mL-1) and C-reactive protein (CRP, 100 μg mL-1) and had no cross-reactivity. Except for bilirubin (2 mg mL-1) and hemoglobin (10 mg mL-1), other common interferences in the serum did not interfere, showing good anti-interference performance. Moreover, 57 clinical serum samples were detected via the chemiluminescence method simultaneously, and the detection results showed a good correlation (R2 = 0.9793, P < 0.01). There was no significant difference between the two performances (P > 0.05). The proposed method has numerous advantages such as high sensitivity, wide linear range, short detection time and simple operation, which provide a new technical reference for the clinical detection of sepsis biomarkers.

Pathogenic epitope-specific monoclonal antibody-based immunoassay for accurate diagnosis and monitoring of tetranectin in sepsis

Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis

Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 As a Marker of Sepsis: a Meta-Analysis

Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis

Establishment of a Novel Homogeneous Nanoparticle-Based Assay for Sensitive Procalcitonin Detection of Ultra Low-Volume Serum Samples

[Development, Identification and Application of 33 Monoclonal Antibodies Against Cardiac Troponin T].

Simultaneous Quantitative Detection of IL-6 and PCT Using SERS magnetic immunoassay with sandwich structure

Recombinant Multiepitope Protein for Diagnosis of Leptospirosis

Preparation of anti-cardiac troponin I monoclonal antibodies and their characterization with surface plasmon resonance biosensor

Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor

The Therapeutic Effect of an Anti-TNF-α/HSA/IL-6R Triple-Specific Fusion Protein Under Experimental Septic Conditions

Biparatopic Nanobody-Based Immunosorbent for the Highly Selective Elimination of Tumor Necrosis Factor-α

Rapid, highly sensitive and quantitative detection of interleukin 6 based on SERS magnetic immunoassay.

An Ultrasensitive Elisa Method for the Detection of Procalcitonin Based on Magnetic Beads and Enzyme-Antibody Labeled Gold Nanoparticles

A point-of-care electrochemical biosensor for the rapid and sensitive detection of biomarkers in murine models with LPS-induced sepsis

Quantitative Detection of Procalcitonin with High Sensitivity, Specificity and Speed Based on SERS Magnetic Immunoassay

Affinity-based 3D-printed microfluidic chip for clinical sepsis detection with CD69, CD64, and CD25

An Ultrasensitive Photoelectrochemical Immunosensor by Integration of Nanobody, TiO2 Nanorod Arrays and ZnS Nanoparticles for the Detection of Tumor Necrosis Factor-Α

The Impact of Antibody Selection on the Detection of Cardiac Troponin I.

A biolayer interferometry-based, aptamer–antibody receptor pair biosensor for real-time, sensitive, and specific detection of the disease biomarker TNF-α

Diagnosis of Streptococcus pneumoniae infection using circulating antibody secreting cells